Skip to main content
All stocks

Nifty Pharma Stocks List

20 pharmaceutical companies — covers domestic + global generics + innovator-style players.

20 constituents · prices refresh daily after NSE close

Open Free Demat to Invest
Top Gainers Today
  • Laurus Labs Ltd.+5.94%
  • Gland Pharma Ltd.+3.70%
  • Ajanta Pharmaceuticals Ltd.+2.76%
  • Wockhardt Ltd.+2.11%
  • Cipla Ltd.+1.94%
Top Losers Today
  • Aurobindo Pharma Ltd.-0.97%
  • Piramal Pharma Ltd.-0.97%
  • Alkem Laboratories Ltd.-0.73%
  • Glenmark Pharmaceuticals Ltd.-0.52%
  • Abbott India Ltd.-0.08%

All Nifty Pharma constituents

20 stocks

SymbolCompanyPrice
ABBOTINDIAAbbott India Ltd.₹25,415Buy
AJANTPHARMAjanta Pharmaceuticals Ltd.₹2,900.7Buy
ALKEMAlkem Laboratories Ltd.₹5,360.5Buy
AUROPHARMAAurobindo Pharma Ltd.₹1,376Buy
BIOCONBiocon Ltd.₹360.6Buy
CIPLACipla Ltd.₹1,335Buy
DIVISLABDivi's Laboratories Ltd.₹6,619.5Buy
DRREDDYDr. Reddy's Laboratories Ltd.Buy
GLANDGland Pharma Ltd.₹1,815.5Buy
GLENMARKGlenmark Pharmaceuticals Ltd.₹2,393.7Buy
IPCALABIpca Laboratories Ltd.₹1,530Buy
JBCHEPHARMJ.B. Chemicals & Pharmaceuticals Ltd.₹2,082.1Buy
LAURUSLABSLaurus Labs Ltd.₹1,166.4Buy
LUPINLupin Ltd.₹2,348.8Buy
MANKINDMankind Pharma Ltd.₹2,257.8Buy
PPLPHARMAPiramal Pharma Ltd.₹160.3Buy
SUNPHARMASun Pharmaceutical Industries Ltd.₹1,823.5Buy
TORNTPHARMTorrent Pharmaceuticals Ltd.₹4,251.8Buy
WOCKPHARMAWockhardt Ltd.₹1,425Buy
ZYDUSLIFEZydus Lifesciences Ltd.₹902.35Buy

⚠️ Important Disclaimer: InvestingPro is not a registered investment advisor or SEBI-registered entity. Content is for educational purposes only and should not be considered personalized financial advice. Please consult a licensed financial professional before making investment decisions. Read full disclaimer →

Nifty Pharmaconstituents sourced from NSE's public archive. Index composition reviewed by NSE Indices Ltd quarterly. Prices are last-close values updated daily after market hours; this is not a live trading feed. Past performance is not a reliable indicator of future results.

No paid rankings
Methodology disclosed
SEBI-compliant
228+ researched articles